Welcome to the Society of Immunotherapy of Cancer.

Our mission is to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy.

Latest Content

Don't miss our 39th Annual Meeting & Pre-Conference Programs

Late-breaking Abstract submissions are open until Sept. 12. Early registration discount ends Aug. 14 - save up to $200 off regular rates!

Explore SITC 2024

Latest Content

SITC Immuno-oncology Drug Development Summit

Sept. 30 – Oct. 1, 2024 in Boston at The Revere Hotel Boston Common

The SITC Immuno-oncology Drug Development Summit will ensure that active, innovative new therapies are rapidly and appropriately moved into clinical testing.

Learn More

Latest Content

2024 Glyco-Immunology Webinar Series

Presented by SITC and the Society for Glycobiology, this FREE webinar series will address the impact of glycobiology on immune regulation, anti-tumor immunity, and immune resistance. Develop more effective cancer immunotherapies by applying principles of glyco-immunology.

Explore Series

Latest Content

Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies

Wednesday, Sept. 11 |  1–5 p.m. ET  |  Virtual – Zoom

Program addresses how to identify and manage CAR T -associated secondary malignancies. FREE for healthcare professionals, students, patients and patient advocates.

Register

SITC Programs

We offer in-person, virtual, and hybrid programs throughout the year for clinicians and researchers. View our upcoming events to see what we can offer you. CME credits are available for certain programs. 

Enduring Materials

Access enduring materials, as permitted by presenters, free of charge for the specific programs for which you were registered. These materials are also available for purchase if you didn't register for the meeting. 

Membership Benefits

Whether seeking to expand your professional network, receive discounted rates to exemplary meetings, stay current with the field, a SITC membership provides value to all experience levels.

Join the Discussion

Connect with industry experts, share insights and access exclusive resources.

Create a SITC account to gain access to cutting-edge research, educational resources and networking opportunities with leading experts in the field.

Login Now

RE: Welcome to the SITC Online community!

Keegan Mager in Community 17 days ago

JITC Logo

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Read the Journal

Support SITC

We offer individuals, corporations, and other organizations a variety of opportunities to support our mission to improve cancer patient outcomes by advancing the science and application of cancer immunotherapy.

Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.

Recent News & Publications

Save the date 2024

SITC’s 39th Annual Meeting & Pre-Conference Programs in Houston, TX.

SITC 2024 is the largest conference focused solely on cancer immunotherapy, providing international leaders from academia, regulatory and government agencies, and industry representatives, with a multidisciplinary environment focused on improving outcomes for all cancer patients.

Learn More


Find out what SITC can do for you.

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.

Become a Member